Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. It offers the reverse phase protein array technology platform that can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. The company was founded on March 18, 2005 and is headquartered in Golden, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Theralink Technologies Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Theralink Technologies Inc market cap is $6,200.00.
What is the 52-week high for Theralink Technologies Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Theralink Technologies Inc 52 week high is $0.0001 as of September 13, 2025.
What is the 52-week low for Theralink Technologies Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Theralink Technologies Inc 52 week low is $0.00 as of September 13, 2025.
What is Theralink Technologies Inc stock price today?
Theralink Technologies Inc stock price today is $1.56.
What was Theralink Technologies Inc stock price yesterday?
Theralink Technologies Inc stock price yesterday was $2.48.
What is the 50-day moving average of Theralink Technologies Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Theralink Technologies Inc 50-day moving average is $0.00.